| Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 13.15 k | 13.15 k | 13.15 k | 13.15 k | 13.15 k | |
| Cash burn (monthly) | (no burn) | 32.44 k | 82.19 k | 311.52 k | 8.53 k | |
| Cash used (since last report) | n/a | 869.08 k | 2.20 mm | 8.35 mm | 228.47 k | |
| Cash remaining | n/a | -855.93 k | -2.19 mm | -8.33 mm | -215.33 k | |
| Runway (months of cash) | n/a | -26.4 | -26.6 | -26.8 | -25.3 | |
| 13F holders | Current |
|---|---|
| Total holders | 2 |
| Opened positions | 0 |
| Closed positions | 0 |
| Increased positions | 0 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 15.45 mm |
| Total shares | 7.25 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Biotech Sponsor | 5.75 mm | $0.00 |
| Vellar Opportunities Fund Master | 1.50 mm | $15.45 mm |
